Cytek Biosciences Inc CTKB

$5.87 +0.06 (1.03%)

Valuation

Market cap
755,201,000
Revenue TTM
$201,490,000
Net income TTM
$-66,540,000
PE ratio
0.00
Forward PE
—
Profit margin
-33.02%
Debt to equity
0.00

Trading

Volume
1,099,400
Avg volume
1,043,646
Day's range
$5.75 – $5.94
Shares out
129,983,000
Stochastic %K
84%
Beta
1.16
Analysts
Strong Sell
Price target
$5.56

Price

Company profile

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approac...

Show more

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Industry
Medical Devices
Sector
Healthcare
Phone
877 922 9835
Website
https://cytekbio.com
Address
47215 Lakeview Blvd, Fremont, United States

Latest news

Stocktwits

macroaxis Oct 3, 12:15 AM
$CTKB Cytek Biosciences options open interest rises in focus this week https://www.macroaxis.com/stock-options/CTKB/Cytek-Biosciences?utm_source=dlvr.it&utm_medium=stocktwits
0 replies
fallondpicks Sep 22, 10:26 PM
14 #stockbreakouts $CTKB, $EMCS, $PGRO, $PS, $RSKD, $VKTX (gap). Two sub-$1, one $1-2.
0 replies
Doozio Sep 17, 11:52 PM
$CTKB let’s bang bro. ONTA 🐒🍌🧠⏰♾️
0 replies
EarningsInsider Aug 5, 9:31 PM
https://www.marketbeat.com/earnings/reports/2026-8-5-cytek-biosciences-inc-stock/ $CTKB Cytek Biosciences Earnings Transcript
0 replies
StocktwitsEarnings Aug 5, 8:29 PM
$CTKB Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.09 down -125.00% YoY • Reported revenue of $48.14M up 5.57% YoY • Cytek Biosciences is updating its revenue outlook for the full year 2026 to be in the range of $207 million to $212 million, raising the midpoint by $1 million total.
0 replies
falcon_trader11 May 29, 8:26 AM
$HYFT $CTKB https://www.linkedin.com/posts/cytek-biosciences_flowcytometry-biotechnology-award-activity-7465824240550739969-51a3?utm_source=share&utm_medium=member_android&rcm=ACoAAECIEmkBGbDMZ9v7VYSwQVbltEseQEb55_8
1 replies
NVDAMillionaire May 20, 12:29 AM
$CTKB Outstanding article that hits the mark on CTKB's current state. So if you want to refresh your CTKB insights or learn about CTKB from scratch, this is a must read. https://everyticker.com/quote/CTKB/analysis/cytek-biosciences-can-a-superior-technology-moat-overcome-a-scale-deficit-in-flow-cytometry-nasdaq-ctkb
0 replies
Superman6009 May 18, 1:24 AM
$CTKB Bottom In? Back up?
0 replies